Xiyu Cao
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Corrigendum to "Efficacy and potential mechanisms of alkaloids in animal models for pulmonary fibrosis: a study integrating preclinical systematic review and meta-analysis, network pharmacology and molecular docking" [Int. Immunopharmacol. 184C (2026) 116908].
Journal: International immunopharmacology
Published: June 09, 2026
Efficacy and potential mechanisms of alkaloids in animal models for pulmonary fibrosis: a study integrating preclinical systematic review and meta-analysis, network pharmacology and molecular docking.
Journal: International immunopharmacology
Published: April 14, 2026
From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension.
Journal: Journal of nanobiotechnology
Published: October 08, 2025
Life's Essential 8 and cardiovascular health: Protective effects on chronic respiratory diseases.
Journal: International journal of cardiology. Cardiovascular risk and prevention
Published: September 25, 2025
Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects.
Journal: Frontiers in pharmacology
Published: September 25, 2025
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease.
Journal: Journal of visualized experiments : JoVE
Published: September 22, 2025
Electroacupuncture as an Adjuvant Therapy for Dyspnea in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
Journal: Journal of visualized experiments : JoVE
Published: August 11, 2025
Wheat Grain Moxibustion as an Adjuvant Therapy for Chronic Fatigue in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
Journal: Journal of visualized experiments : JoVE
Published: August 11, 2025
Natural active botanical metabolites: targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease.
Journal: Frontiers in pharmacology
Published: April 14, 2025
Global, regional, and national burden of young COPD, 1990-2021, with forecasts to 2050: a systematic analysis for the global burden of disease study 2021.
Journal: BMC public health
Published: October 22, 2024
Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning.
Journal: BMC medical informatics and decision making
Published: June 16, 2024
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk.
Journal: Frontiers in immunology
Published: November 12, 2023
Last Updated: 09/26/2026